1Department of General Surgery, The Thirteenth People's Hospital of Chongqing, Chongqing 400010, China
2Department of Hepatobiliary Surgery, Suining Central Hospital, Suining 629000, China
American Journal of Cancer Prevention.
2016,
Vol. 4 No. 2, 23-25
DOI: 10.12691/ajcp-4-2-1
Copyright © 2016 Science and Education PublishingCite this paper: Cheng Luo, Yakun Wu, Shaoyong Liang. Role of TACE in Patients with Hepatocellular Carcinoma before Liver Transplantation.
American Journal of Cancer Prevention. 2016; 4(2):23-25. doi: 10.12691/ajcp-4-2-1.
Correspondence to: Shaoyong Liang, Department of General Surgery, The Thirteenth People's Hospital of Chongqing, Chongqing 400010, China. Email:
353827514@qq.comAbstract
Transarterial chemoembolization (TACE) can prevent tumor progression in patients with hepatocellular carcinoma awaiting liver transplantation. This article introduces the effect of TACE before liver transplantation in terms of dropout rate, improvement in overall survival, prediction of survival, and its application as down-stage therapy.
Keywords